Abstract
The aim of the study was to evaluate the clinical significance of serum (S) and synovial fluid (SF) interleukin (IL)-18, IL-15, IL-12 and the tumor necrosis factor alpha (TNF-α) measurements in relation to laboratory and clinical measures of disease activity of patients with active rheumatoid arthritis (RA). Sixty-four patients with RA and 25 patients with osteoarthritis (OA) were included in this study. RA activity was determined using the Disease Activity Score (DAS) 28 index. Concentrations of IL-18, IL-15, IL-12 and TNF-α were measured by ELISA. Serum C-reactive protein (CRP) levels were also determined. Cross-sectional correlations between S and SF levels of cytokines and values of DAS 28 index were calculated. The results have shown that IL-18, IL-15, IL-12 and TNF-α levels in S and SF of patients with RA were significantly higher than the levels obtain from patients with OA (p<0.01). Significantly higher levels of IL-18, IL-15 and TNF-α were found in the SF compared to the S of patients with RA (p<0.01). Significantly higher S and SF levels of all four cytokines and serum CRP values were found in RA patients with high disease activity (DAS 28>5.1) compared to those with mild (DAS 28>3.2) and low disease activity (DAS 28>2.6) (p<0.01). Serum and SF concentrations of all four cytokines positively correlated with DAS 28 index values, i.e., disease activity. A poor correlation was found for S and SF IL-12 whereas the highest coefficient of correlation was found for SF IL-18 (r=0.879, p<0.01), and SF TNF-α (r=0.827, p<0.01) and disease activity in this study. Strong correlation was found between SF TNF-α and SF IL-18 levels (r=0.732, p<0.01). In conclusion, SF IL-18 and TNF-α levels in RA patients are good indicators of disease activity. The results obtained support the use of the DAS in clinical practice as a reliable method in assessing disease activity in RA patients.
Similar content being viewed by others
References
Kawashima M, Miossec P (2004) Decreased response to IL-12 and IL-18 of peripheral blood cells in rheumatoid arthritis. Arthritis Res Ther 6:R39–R45
Joosten LA, Radstake TR, Lubberts E, van den Bersselaar LA, van Riel PL, van Lent PL et al (2003) Association of interleukin-18 expression with enhanced levels of both interleukin-1beta and tumor necrosis alpha in knee synovial tissue of patients with rheumatoid arthritis. Arthritis Rheum 48(2):339–347
Leung PB, McInnes BI, Esfandiari E, Wei XQ, Liew YF (2000) Combined effects of IL-12 and IL-18 on the induction of collagen-induced arthritis. J Immunol 164:6495–6502
Gracie AJ, Forsey JR, Ling Chan W, Gilmour A, Leung PB, Greer RM et al (1999) A proinflammatory role for IL-18 in rheumatoid arthritis. J Clin Invest 104:1393–1401
McInnes BI, Gracie AJ, Hornett M, Hornett W, Liew YF (2003) New strategies to control inflammatory synovitis: interleukin 15 and beyond. Ann Rheum Dis 62:ii51–ii54
Prevoo LM, Hof AM, Kuper HH, Leeuwen AM, Putte BL, Riel LP (1995) Modified disease activity scores that include twenty-eight-joint counts. Arthritis Rheum 38:44–48
Stone AM, Payne U, Pacheco-Tena C, Inman DR (2004) Cytokine correlates of clinical response patterns to infliximab treatment of ankylosing spondylitis. Ann Rheum Dis 63:84–87
Liew YF, McInnes BI (2002) Role of interleukin 15 and interleukin 18 in inflammatory response. Ann Rheum Dis 61:ii100–ii102
Bresnihan B, Roux-Lombard P, Murphy E, Kane D, FitzGerald O, Dayer MJ (2002) Serum interleukin 18 and interleukin 18 binding protein in rheumatoid arthritis. Ann Rheum Dis 61:726–729
Klimiuk AP, Sierakowski S, Latosiewicz R, Cylwik B, Skowronski J, Chwiecko J (2001) Serum cytokines in different histological variants of rheumatoid arthritis. J Rheumatol 28:1211–1217
Gonzalez-Alvaro I, Ortiz AM, Garcia-Vicuna R, Balsa A, Pascual-Salcedo Laffon A (2003) Increased serum levels of interleukin-15 in rheumatoid arthritis with long-term disease. Clin Exp Rheumatol 21(5):639–642
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Petrovic-Rackov, L., Pejnovic, N. Clinical significance of IL-18, IL-15, IL-12 and TNF-α measurement in rheumatoid arthritis. Clin Rheumatol 25, 448–452 (2006). https://doi.org/10.1007/s10067-005-0106-0
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10067-005-0106-0